Interleukin 1 receptor antagonist (IL-1ra) prevents or cures pulmonary fibrosis elicited in mice by bleomycin or silica
- 1 January 1993
- Vol. 5 (1) , 57-61
- https://doi.org/10.1016/1043-4666(93)90024-y
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Blocking IL-1: interleukin 1 receptor antagonist in vivo and in vitroImmunology Today, 1991
- Fibrogenic cytokines: the role of immune mediators in the development of scar tissueImmunology Today, 1991
- Interleukin-1 receptor antagonist reduces mortality from endotoxin shockNature, 1990
- Interleukin 1 (IL-1) gene expression, synthesis, and effect of specific IL-1 receptor blockade in rabbit immune complex colitis.Journal of Clinical Investigation, 1990
- Regulation of Alloreactivity in Vivo by a Soluble Form of the Interleukin-1 ReceptorScience, 1990
- Requirement of tumour necrosis factor for development of silica-induced pulmonary fibrosisNature, 1990
- Primary structure and functional expression from complementary DNA of a human interleukin-1 receptor antagonistNature, 1990
- Tumor necrosis factor/cachectin plays a key role in bleomycin-induced pneumopathy and fibrosis.The Journal of Experimental Medicine, 1989
- Phagocytosis and inflammatory stimuli induce GM-CSF mRNA in macrophages through posttranscriptional regulationCell, 1987
- Tumour necrosis factor as immunomodulator and mediator of monocyte cytotoxicity induced by itself, γ-interferon and interleukin-1Nature, 1986